Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale VP Finance & Accounting sold 5,000 shares at an average $17.22 ($86,102)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Conversion 10% owner acquired 1,785,714 shares (conversion)
  9. 4 Open-market buy 10% owner bought 93,750 shares at $16.00 ($1,500,000)
  10. 4 Open-market buy 10% owner bought 81,250 shares at $16.00 ($1,300,000)
  11. 4 Open-market buy 10% owner bought 81,250 shares at $16.00 ($1,300,000)
  12. 4 Open-market buy 10% owner bought 118,750 shares at $16.00 ($1,900,000)
  13. 4 Open-market buy 10% owner bought 140,000 shares at an average $15.84 ($2,217,495)
  14. 4 Open-market buy Director bought 81,250 shares at $16.00 ($1,300,000)
  15. 4 Conversion 10% owner acquired 464,285 shares (conversion)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 12 · 221 filings